ScholarIQanswers from OpenAlex

Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance

PaperCitations, authors & open-access status

Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance have?

ScholarIQcitation count

Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance has 75 citations in the OpenAlex counts ScholarIQ stores.

When was Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance published?

ScholarIQyear

Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance has 2019 year in the ScholarIQ index.

What is the open-access status of Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance?

ScholarIQoa status

Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance has green oa status in the ScholarIQ index.

What is the DOI of Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance?

ScholarIQdoi

The DOI for Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance is on the source record.

What is the PMID of Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance?

ScholarIQpmid

The PMID for Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance is on the source record.

What is the OpenAlex record for Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance?

ScholarIQopenalex

The OpenAlex for Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial